Analyze Diet
Medicine and science in sports and exercise2006; 38(2); 262-267; doi: 10.1249/01.mss.0000185108.63028.04

Changes in adipopnectin, leptin, and fat mass after clenbuterol treatment in horses.

Abstract: Adipose tissue plays complex role(s) in metabolic and endocrine control. To date, little work has been done in the horse regarding adipocytokines. Objective: This study was conducted to determine whether therapeutic levels of chronic beta-agonist administration, exercise, or both could alter their concentrations. Methods: A total of 23 standard-bred mares were divided into four experimental groups: clenbuterol (2.4 microg.kg(-1) bw twice daily for 8 wk) plus exercise (8 wk, 20 min.d(-1) at 50% VO2max; CLENEX; N = 6), clenbuterol only (CLEN; N = 6), exercise only (EX; N = 5), and control (CON; N = 6). Rump fat thickness was measured using B-mode ultrasound and percent body fat (%fat) was calculated. Plasma adiponectin and leptin concentrations were measured using radioimmunoassay (RIA). In the absence of purified equine adiponectin or leptin, results were expressed as human equivalents of immunoreactive adipocytokines. Results: The change in plasma immunoreactive (ir)-adiponectin HE concentration was negatively correlated (r = -0.520; P = 0.01) to the change in fat mass and positively correlated (r = 0.446; P = 0.03) to the change in fat-free mass. The change in plasma ir-leptin HE concentration was positively correlated (r = 0.550; P = 0.02) to the change in fat mass and negatively correlated (r = -0.473; P < 0.05) to the change in fat-free mass. Conclusions: These data demonstrate that a chronic clenbuterol administration alters the concentrations of the adipocytokines adiponectin and leptin in horses. These changes may play a role in previously reported repartitioning effects of clenbuterol.
Publication Date: 2006-03-15 PubMed ID: 16531894DOI: 10.1249/01.mss.0000185108.63028.04Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research paper investigates how the use of the drug clenbuterol, with or without exercise, affects levels of adiponectin and leptin – two key hormones involved in regulating body fat and energy metabolism – in horses. The results indicate that chronic clenbuterol treatment can alter these hormone levels and potentially affect fat distribution in the animal.

Objective and Methodology

Given the complex roles of adipose tissue in metabolic and endocrine balance, the researchers conducted this study to measure the effects of clenbuterol, exercise, or both on adipocytokine concentrations in horses. The research involved:

  • 23 standard-bred mares separated into four groups: clenbuterol plus exercise (CLENEX), clenbuterol only (CLEN), exercise only (EX), and control (CON).
  • Administering clenbuterol (2.4 microg.kg(-1) body weight twice daily for eight weeks) and/or implementing a regimented exercise program (20 minutes per day at 50% VO2max for eight weeks).
  • Measuring rump fat thickness using B-mode ultrasound and calculating the percentage body fat.
  • Assessing plasma concentrations of adiponectin and leptin through radioimmunoassay (RIA), with results expressed as human equivalents due to the lack of purified equine adiponectin or leptin.

Key Findings

The researchers analyzed the link between changes in adiponectin and leptin levels and changes in fat and fat-free mass, revealing that:

  • The change in adiponectin concentration was negatively correlated with the change in fat mass and positively correlated with the change in fat-free mass.
  • The change in leptin concentration showed a positive correlation with the change in fat mass and a negative correlation with the change in fat-free mass.

Conclusions

The findings show that chronic administration of clenbuterol can alter adiponectin and leptin concentrations in horses. The changes to these hormone levels could be involved in the previously reported repartitioning effects of clenbuterol, whereby fat and lean body mass quantities are redistributed within the body. Thus, clenbuterol may have a significant impact on the body composition and metabolic parameters of treated horses.

Cite This Article

APA
Kearns CF, McKeever KH, Malinowski K. (2006). Changes in adipopnectin, leptin, and fat mass after clenbuterol treatment in horses. Med Sci Sports Exerc, 38(2), 262-267. https://doi.org/10.1249/01.mss.0000185108.63028.04

Publication

ISSN: 0195-9131
NlmUniqueID: 8005433
Country: United States
Language: English
Volume: 38
Issue: 2
Pages: 262-267

Researcher Affiliations

Kearns, Charles F
  • Equine Science Center, Department of Animal Science, Rutgers the State University of New Jersey, New Brunswick, NJ 08901-8525, USA.
McKeever, Kenneth H
    Malinowski, Karyn

      MeSH Terms

      • Adiponectin / blood
      • Adipose Tissue / drug effects
      • Adrenergic beta-Agonists / pharmacology
      • Analysis of Variance
      • Animals
      • Body Composition / drug effects
      • Clenbuterol / pharmacology
      • Horses
      • Leptin / blood
      • Physical Conditioning, Animal

      Citations

      This article has been cited 1 times.
      1. Knych HK, Harrison LM, Steinmetz SJ, Chouicha N, Kass PH. Differential expression of skeletal muscle genes following administration of clenbuterol to exercised horses.. BMC Genomics 2016 Aug 9;17:596.
        doi: 10.1186/s12864-016-2945-2pubmed: 27506674google scholar: lookup